Superficial femoral artery occlusion: Nitinol stents achieve flow and reduce the need for medications better than balloon angioplasty alone

Journal of Invasive Cardiology

Volumn 15, Issue 4, 2003, Pages 198-200

  Cho, Leslie ^a,e   Roffi, Marco ^b   Mukherjee, Debabrata ^c   Bhatt, Deepak L ^d   Bajzer, Christopher ^d   Yadav, Jay S ^d  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e Bldg 110 ^*  (United States)

Author keywords

Balloon angioplasty; SFA; Stents

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITINOL; PENTOXIFYLLINE;

ADULT; AGED; ARTERY BLOOD FLOW; ARTICLE; CHRONIC DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTERMITTENT CLAUDICATION; INTERVENTIONAL RADIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; RISK FACTOR; STENT; SUPERFICIAL FEMORAL ARTERY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ALLOYS; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; COMBINED MODALITY THERAPY; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; OHIO; STENTS; TREATMENT OUTCOME;

EID: 0037390929     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. BENESTENT Study Group. N Engl J Med 1994;331:489-495.
2. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994;331:496-501.
3. Gray BH, Sullivan TM, Childs MB, et al. High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg 1997;25:74-83.
4. Gray BH, Olin JW. Limitations of percutaneous transluminal angioplasty with stenting for femoropopliteal arterial occlusive disease. Semin Vasc Surg 1997;10:8-16.
5. Ansel GM. Endovascular treatment of superficial femoral and popliteal arterial occlusive disease. J Invas Cardiol 2000;12:382-388.
6. Cejna M, Thurnher S, Illiasch H, et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: A multicenter prospective randomized study. J Vasc Intervent Radiol 2001;12:23-31.
7. Conroy RM, Gordon IL, Tobis JM, et al. Angioplasty and stent placement in chronic occlusion of the superficial femoral artery: Technique and results. J Vasc Intervent Radiol 2000;11:1009-1020.
8. Lammer J, Dake MD, Bleyn J, et al. Peripheral arterial obstruction: Prospective study of treatment with a transluminally placed self-expanding stent-graft. International Trial Study Group. Radiology 2000;217:95-104.
9. Lampmann LE. Stenting in the femoral superficial artery: An overview. Eur J Radiol 1999;29:276-279.
10. Henry M, Amor M, Ethevenot G, et al. Palmaz stent placement in iliac and femoropopliteal arteries: Primary and secondary patency in 310 patients with 2-4 year follow-up. Radiology 1995;197:167-174.
11. White C, Ramee S, Bendick P, Safian R. Peripheral Vascular Intervention, Third Edition. Royal Oak: Physicians' Press: 2001.
12. Duda SH, Wiskirchen J, Tepe G, et al. Physical properties of endovascular stents: An experimental comparison. J Vasc Intervent Radiol 2000;11:645-654.